Axinn partner Chad Landmon participated in a video interview with The Center for Biosimilars, where he discussed the Biden Biosimilars initiative. During the interview, he put these initiatives into context with background information and insight into the likely pharmaceutical industry impact and response.

Click here to access the interview.